Dr. Hupertz was a graduate of Rensselaer Polytechnic Institute in Troy, NY (1974-1978) and received her BS in Biology. She attended the University of Rochester School of Medicine and Dentistry, Rochester, NY and graduated in 1982 with MD. Internship and residency was completed at Rainbow Babies & Children's (RB&C) Hospital, Cleveland, OH by 1985 and Pediatric Gi and Hepatology fellowship by 1988. She maintains 3 board certifications which include: Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology. 

Vera stayed on as Staff Physician at Rainbow Babies and Hospital and achieved the level of Associate Professor of Medicine at Case Western Reserve University. She was made Medical Director of the Pediatric Liver Transplant Team, and was co-director of the Residency Training Program at RB&C. In addition to the above, I developed a residency curriculum for Chronic Care to be used at Health Hill Hospital (now Cleveland Clinic Children's Hospital for Rehabilitation). 

She became a staff physician at the Cleveland Clinic Foundation in July of 2000 and currently has a joint appointment with the Department of Transplant Surgery. She is Medical Director of Pediatric Liver Transplantation. She is Vice Chair of Quality Improvement for the Children's Hospital and Pediatric Institute at Cleveland Clinic. Current interests are liver disease (especially neonatal disease) and liver transplantation, as well as inflammatory bowel diseases

Dr. Steven Bailey is the Chairman of Internal Medicine at LSU Health Shreveport and the Malcolm Feist Chair of Interventional Cardiology. He is a Tenured and Emeritus Professor of Medicine and Radiology and previous Chief of the Janey and Dolph Briscoe Jr. Division of Cardiology at the University of Texas Health Science Center in San Antonio, Texas. Dr. Bailey received his medical degree from the University of Oregon Health Science Center at Portland and did his medicine residency and cardiology fellowship at Fitzsimmons Army Medical Center in Aurora, Colorado. He is board certified by the American Board of Internal Medicine with subspecialty board certification in both Cardiovascular Disease and Interventional Cardiology. Dr. Bailey's clinical focus is in Adult Congenital/Structural and Valvular heart disease in addition to Coronary Atherosclerotic Disease. His research laboratory is involved in investigating the effects of NOX subtypes in promoting cardiovascular disease and Pulmonary Endothelial cell prothrombic response to Covid 19 viral infection. He has translational research in the field of nanotechnologies and nanosensors and holds several patents in these fields. He was the Program Director for Interventional Cardiology at UTHSCSA from 1999 to 2019. Dr. Bailey chaired the UTHSCSA Promotion and Tenure committee. Dr. Bailey is a Past President of the Society for Cardiovascular Angiography and Interventions (SCAI) and is currently the Editor in Chief of Catheterization and Cardiovascular Interventions. He is a Master Fellow of SCAI, a Master Fellow of ACP, a Fellow of the American College of Cardiology, and a Fellow of the American Heart Association. He is a member of the Association of the Professors of Medicine, Association of University Cardiologists, the Association of Cardiology Professors, as well as the International Andreas Greuntizig Society.